293 related articles for article (PubMed ID: 21982726)
1. Ovarian hyperandrogenism in adolescents and young women with type I diabetes is primarily related to birth weight and body mass index.
Bizzarri C; Benevento D; Ravà L; Patera IP; Schiaffini R; Ciampalini P; Giannone G; Cappa M
Fertil Steril; 2011 Dec; 96(6):1497-1502.e1. PubMed ID: 21982726
[TBL] [Abstract][Full Text] [Related]
2. Plasma metastin levels are negatively correlated with insulin resistance and free androgens in women with polycystic ovary syndrome.
Panidis D; Rousso D; Koliakos G; Kourtis A; Katsikis I; Farmakiotis D; Votsi E; Diamanti-Kandarakis E
Fertil Steril; 2006 Jun; 85(6):1778-83. PubMed ID: 16650418
[TBL] [Abstract][Full Text] [Related]
3. The effect of serum and intrafollicular insulin resistance parameters and homocysteine levels of nonobese, nonhyperandrogenemic polycystic ovary syndrome patients on in vitro fertilization outcome.
Nafiye Y; Sevtap K; Muammer D; Emre O; Senol K; Leyla M
Fertil Steril; 2010 Apr; 93(6):1864-9. PubMed ID: 19171332
[TBL] [Abstract][Full Text] [Related]
4. Dietary glycemic index is associated with less favorable anthropometric and metabolic profiles in polycystic ovary syndrome women with different phenotypes.
Graff SK; Mário FM; Alves BC; Spritzer PM
Fertil Steril; 2013 Oct; 100(4):1081-8. PubMed ID: 23830153
[TBL] [Abstract][Full Text] [Related]
5. Adrenal androgen excess and body mass index in polycystic ovary syndrome.
Moran C; Arriaga M; Arechavaleta-Velasco F; Moran S
J Clin Endocrinol Metab; 2015 Mar; 100(3):942-50. PubMed ID: 25514100
[TBL] [Abstract][Full Text] [Related]
6. Insulin resistance and hyperandrogenism have no substantive association with birth weight in adolescents with polycystic ovary syndrome.
Fulghesu AM; Manca R; Loi S; Fruzzetti F
Fertil Steril; 2015 Mar; 103(3):808-14. PubMed ID: 25637475
[TBL] [Abstract][Full Text] [Related]
7. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
Panidis D; Farmakiotis D; Rousso D; Kourtis A; Katsikis I; Krassas G
Fertil Steril; 2008 Apr; 89(4):899-906. PubMed ID: 17980364
[TBL] [Abstract][Full Text] [Related]
8. Insulin resistance is not strictly associated with energy intake or dietary macronutrient composition in women with polycystic ovary syndrome.
Toscani MK; Mario FM; Radavelli-Bagatini S; Spritzer PM
Nutr Res; 2011 Feb; 31(2):97-103. PubMed ID: 21419313
[TBL] [Abstract][Full Text] [Related]
9. The insulin-resistant phenotype of polycystic ovary syndrome.
Svendsen PF; Madsbad S; Nilas L
Fertil Steril; 2010 Aug; 94(3):1052-8. PubMed ID: 19580964
[TBL] [Abstract][Full Text] [Related]
10. Adolescent polycystic ovary syndrome due to functional ovarian hyperandrogenism persists into adulthood.
Rosenfield RL; Ehrmann DA; Littlejohn EE
J Clin Endocrinol Metab; 2015 Apr; 100(4):1537-43. PubMed ID: 25675386
[TBL] [Abstract][Full Text] [Related]
11. Improvement of hyperandrogenism and hyperinsulinemia during pregnancy in women with polycystic ovary syndrome: possible effect in the ovarian follicular mass of their daughters.
Crisosto N; Echiburú B; Maliqueo M; Pérez V; Ladrón de Guevara A; Preisler J; Sánchez F; Sir-Petermann T
Fertil Steril; 2012 Jan; 97(1):218-24. PubMed ID: 22088206
[TBL] [Abstract][Full Text] [Related]
12. The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome.
Amato MC; Galluzzo A; Finocchiaro S; Criscimanna A; Giordano C
Clin Endocrinol (Oxf); 2008 Jul; 69(1):52-60. PubMed ID: 18034780
[TBL] [Abstract][Full Text] [Related]
13. Androgen excess is associated with the increased carotid intima-media thickness observed in young women with polycystic ovary syndrome.
Luque-Ramírez M; Mendieta-Azcona C; Alvarez-Blasco F; Escobar-Morreale HF
Hum Reprod; 2007 Dec; 22(12):3197-203. PubMed ID: 17933750
[TBL] [Abstract][Full Text] [Related]
14. Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome.
Kazerooni T; Dehghan-Kooshkghazi M
Gynecol Endocrinol; 2003 Feb; 17(1):51-6. PubMed ID: 12724019
[TBL] [Abstract][Full Text] [Related]
15. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z
Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
[TBL] [Abstract][Full Text] [Related]
16. Type 2 diabetes and the polycystic ovary syndrome.
Pelusi B; Gambineri A; Pasquali R
Minerva Ginecol; 2004 Feb; 56(1):41-51. PubMed ID: 14973409
[TBL] [Abstract][Full Text] [Related]
17. [Exploration of the classification of polycystic ovarian syndrome].
Lin JF; Li X; Zhu MW
Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):684-8. PubMed ID: 17199924
[TBL] [Abstract][Full Text] [Related]
18. Hyperinsulinemia does not influence androgens/estrogens ratio in patients with polycystic ovarian syndrome.
Panidis DK; Rousso DH; Matalliotakis IM; Kourtis AI; Vlassis GD; Koumantakis EE
Int J Fertil Womens Med; 1999; 44(6):301-6. PubMed ID: 10617252
[TBL] [Abstract][Full Text] [Related]
19. Ovarian size and blood flow in women with polycystic ovary syndrome and their correlations with endocrine parameters.
Carmina E; Orio F; Palomba S; Longo RA; Lombardi G; Lobo RA
Fertil Steril; 2005 Aug; 84(2):413-9. PubMed ID: 16084883
[TBL] [Abstract][Full Text] [Related]
20. Influence of body mass index on measured and calculated androgen parameters in adult women with Hirsutism and PCOS.
Cupisti S; Dittrich R; Binder H; Kajaia N; Hoffmann I; Maltaris T; Beckmann MW; Mueller A
Exp Clin Endocrinol Diabetes; 2007 Jun; 115(6):380-6. PubMed ID: 17701884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]